scholarly journals Saturated and unsaturated fat diets impair hippocampal glutamatergic transmission in adolescent mice

2021 ◽  
pp. 105429
Author(s):  
J. Fernández-Felipe ◽  
B. Merino ◽  
A.B. Sanz-Martos ◽  
A. Plaza ◽  
A. Contreras ◽  
...  
Endocrinology ◽  
2010 ◽  
Vol 151 (9) ◽  
pp. 4187-4196 ◽  
Author(s):  
G. Frangioudakis ◽  
J. Garrard ◽  
K. Raddatz ◽  
J. L. Nadler ◽  
T. W. Mitchell ◽  
...  

Lipid-induced insulin resistance is associated with intracellular accumulation of inhibitory intermediates depending on the prevalent fatty acid (FA) species. In cultured myotubes, ceramide and phosphatidic acid (PA) mediate the effects of the saturated FA palmitate and the unsaturated FA linoleate, respectively. We hypothesized that myriocin (MYR), an inhibitor of de novo ceramide synthesis, would protect against glucose intolerance in saturated fat-fed mice, while lisofylline (LSF), a functional inhibitor of PA synthesis, would protect unsaturated fat-fed mice. Mice were fed diets enriched in saturated fat, n-6 polyunsaturated fat, or chow for 6 wk. Saline, LSF (25 mg/kg · d), or MYR (0.3 mg/kg · d) were administered by mini-pumps in the final 4 wk. Glucose homeostasis was examined by glucose tolerance test. Muscle ceramide and PA were analyzed by mass spectrometry. Expression of LASS isoforms (ceramide synthases) was evaluated by immunoblotting. Both saturated and polyunsaturated fat diets increased muscle ceramide and induced glucose intolerance. MYR and LSF reduced ceramide levels in saturated and unsaturated fat-fed mice. Both inhibitors also improved glucose tolerance in unsaturated fat-fed mice, but only LSF was effective in saturated fat-fed mice. The discrepancy between ceramide and glucose tolerance suggests these improvements may not be related directly to changes in muscle ceramide and may involve other insulin-responsive tissues. Changes in the expression of LASS1 were, however, inversely correlated with alterations in glucose tolerance. The demonstration that LSF can ameliorate glucose intolerance in vivo independent of the dietary FA type indicates it may be a novel intervention for the treatment of insulin resistance.


Author(s):  
Panayiotis N. Adamopoulos ◽  
Christakis M. Papamichael ◽  
Antonios Zampelas ◽  
Spyros D. Moulopoulos
Keyword(s):  

1986 ◽  
Vol 64 (6) ◽  
pp. 836-839 ◽  
Author(s):  
Jacques Genest

A succinct overview of the nutritional management of hypertension, past, present, and future is presented. Prior to 1945, the low sodium diet and the rice–fruit diet were shown to be effective in reducing the blood pressure to normal levels in 35–40% of hypertensive patients. Between 1945 and the present, many studies were made on the effects of alcohol, water hardness, obesity, moderate restriction of sodium with increased potassium intake, increased dietary calcium, low animal and high unsaturated fat intake, and increased amounts of fiber in the diet. Criticisms are made of the very small magnitude, even if statistically significant, of blood pressure decreases and the too-short control periods in many instances, and also concerning the assumption of use of 24-h urinary sodium as an accurate index of the sodium intake, and of urinary creatinine as a physiological reference standard against the excretion of sodium. The author mentions, for possible future research, long-term studies of the effects of diets moderately restricted in sodium and high in potassium, of reducing weight and increasing physical activity in obese hypertensives, and of low animal and high polyunsaturated fat diets in patients with mild essential hypertension.


2015 ◽  
Vol 148 (4) ◽  
pp. S-58
Author(s):  
Krutika Patel ◽  
Pawan Noel ◽  
Ram Trivedi ◽  
Cristiane de Oliveira ◽  
Vijay P. Singh

1982 ◽  
Vol 41 (2-3) ◽  
pp. 221-240 ◽  
Author(s):  
A. Kuksis ◽  
J.J. Myher ◽  
K. Geher ◽  
G.J.L. Jones ◽  
J. Shepherd ◽  
...  

2019 ◽  
Vol 33 (S1) ◽  
Author(s):  
Elizabeth DeWitt ◽  
Ian Dysinger ◽  
Zachary Larmer ◽  
Stephen C Kolwicz

2006 ◽  
Vol 96 (S2) ◽  
pp. S68-S78 ◽  
Author(s):  
Amy E. Griel ◽  
Penny M. Kris-Etherton

Tree nuts have a fatty acid profile that favourably affects blood lipids and lipoproteins. They are low in saturated fat and high in unsaturated fatty acids and are rich sources of other nutrients. An extensive database consistently shows total and LDL cholesterol-lowering effects of diets low in saturated fat and cholesterol and high in unsaturated fat provided by a variety of tree nuts. Collectively, a summary of studies conducted to date shows that tree nuts reduce LDL cholesterol by 3–19 % compared with Western and lower-fat diets. Nuts also contain many nutrients and bioactive compounds that appear to contribute to the favourable effects on lipids and lipoproteins – these include plant sterols, dietary fibre and antioxidants. Because of their unique nutrient profile, nuts can be part of a diet that features multiple heart-healthy foods resulting in a cholesterol lowering response that surpasses that of cholesterol-lowering diets typically used to reduce CVD risk.


Sign in / Sign up

Export Citation Format

Share Document